{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:32Z","timestamp":1791297812168,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"INGM"},{"name":"Ghent University"},{"name":"Rutgers University"},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.virol.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T09:11:40Z","timestamp":1428311500000},"page":"221-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Advances in experimental systems to study hepatitis C virus in vitro and in vivo"],"prefix":"10.1016","volume":"479-480","author":[{"given":"Maria Teresa","family":"Catanese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-1527","authenticated-orcid":false,"given":"Marcus","family":"Dorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2015.03.014_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virusres.2006.12.011","article-title":"Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA","volume":"125","author":"Abe","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2015.03.014_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.26371","article-title":"New horizons in hepatitis C antiviral therapy with direct-acting antivirals","volume":"58","author":"Aghemo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib3","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"447\u2013455","key":"10.1016\/j.virol.2015.03.014_bib4","first-page":"e441","article-title":"Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice","volume":"145","author":"Akazawa","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib5","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andre","year":"2002","journal-title":"J Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib6","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/hep.24557","article-title":"Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells","volume":"54","author":"Andrus","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2015.03.014_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","article-title":"Assembly of infectious hepatitis C virus particles","volume":"19","author":"Bartenschlager","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virol.2015.03.014_bib9","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.79.9.5774-5785.2005","article-title":"Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes","volume":"79","author":"Barth","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib10","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2015.03.014_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4161\/rna.21208","article-title":"Targeting ribosome assembly on the HCV RNA using a small RNA molecule","volume":"9","author":"Bhat","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.virol.2015.03.014_bib13","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-4939-1453-1_31","article-title":"A chimeric mouse model to study immunopathogenesis of HCV infection","volume":"1213","author":"Bility","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2015.03.014_bib15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/nprot.2012.083","article-title":"Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis","volume":"7","author":"Bility","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virol.2015.03.014_bib16","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib17","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/JVI.77.5.3181-3190.2003","article-title":"Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture","volume":"77","author":"Blight","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib18","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0165-2427(92)90170-U","article-title":"Engraftment of severe combined immune deficient\/beige mice with bovine foetal lymphoid tissues","volume":"34","author":"Boermans","year":"1992","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.virol.2015.03.014_bib20","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib21","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.212532699","article-title":"Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees","volume":"99","author":"Bukh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1099\/vir.0.010983-0","article-title":"Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells","volume":"90","author":"Bungyoku","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","author":"Cacoub","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.virol.2015.03.014_bib24","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.01102-13","article-title":"Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission","volume":"87","author":"Catanese","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib25","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2013.01.005","article-title":"Development of a robust luciferase reporter 1b\/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors","volume":"98","author":"Chan","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2015.03.014_bib27","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1128\/JVI.00586-06","article-title":"Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities","volume":"80","author":"Chang","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/cr.2014.116","article-title":"Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.virol.2015.03.014_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib31","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1128\/JVI.07235-11","article-title":"Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone","volume":"86","author":"Date","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib32","doi-asserted-by":"crossref","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Science Transl. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2015.03.014_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"Dorner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2015.03.014_bib35","series-title":"HCV and Blood Cells: How Can We Distinguish Infection from Association? HCV Infection and Cryoglobulinemia","author":"Dustin","year":"2011"},{"key":"10.1016\/j.virol.2015.03.014_bib36","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.virol.2015.03.014_bib38","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J. Exp. Med."},{"issue":"634-643","key":"10.1016\/j.virol.2015.03.014_bib39","first-page":"e636","article-title":"Hepatitis C virus infects the endothelial cells of the blood\u2013brain barrier","volume":"142","author":"Fletcher","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib40","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1128\/JVI.00104-06","article-title":"Diverse CD81 proteins support hepatitis C virus infection","volume":"80","author":"Flint","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/jhep.2000.9877","article-title":"Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV","volume":"32","author":"Forns","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrgastro.2011.259","article-title":"Hepatitis: brain endothelial cells support HCV entry and replication.","volume":"9","author":"Franks","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2015.03.014_bib43","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1073\/pnas.1312772110","article-title":"Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)","volume":"110","author":"Fuller","year":"2013","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib44","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1099\/vir.0.053868-0","article-title":"Analysis of hepatitis C virus core\/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1\u20137","volume":"94","author":"Galli","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib45","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1128\/JVI.00526-10","article-title":"Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture","volume":"84","author":"Gastaminza","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virusres.2003.12.029","article-title":"Sequence requirements for the development of a chimeric HCV replicon system","volume":"100","author":"Gates","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2015.03.014_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/nar\/gkt852","article-title":"Miravirsen (SPC3649) can inhibit the biogenesis of miR-122","volume":"42","author":"Gebert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2015.03.014_bib48","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib49","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1128\/AAC.01176-13","article-title":"Adapted J6\/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor","volume":"57","author":"Gottwein","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib50","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.00049-11","article-title":"Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A","volume":"85","author":"Gottwein","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib51","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","article-title":"Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies","volume":"84","author":"Gottwein","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib52","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2011.06.004","article-title":"Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3\/4A protease recombinant viruses","volume":"141","author":"Gottwein","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib56","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1099\/vir.0.80006-0","article-title":"Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon","volume":"85","author":"Graziani","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib57","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1128\/AAC.00527-13","article-title":"Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein","volume":"57","author":"Gu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2015.03.014_bib59","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/AAC.00533-08","article-title":"Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors","volume":"52","author":"Herlihy","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2013.01.019","article-title":"Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein","volume":"439","author":"Horwitz","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.014_bib61","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib62","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JVI.01815-13","article-title":"Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly","volume":"88","author":"Hueging","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib63","first-page":"1328","article-title":"Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro","volume":"26","author":"Iacovacci","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib64","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1128\/JVI.76.6.2997-3006.2002","article-title":"Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells","volume":"76","author":"Ikeda","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2009.04.007","article-title":"A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication","volume":"83","author":"Iro","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2015.03.014_bib66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000317690","article-title":"Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection","volume":"2","author":"Ito","year":"2010","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.virol.2015.03.014_bib67","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/593021","article-title":"Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection","volume":"198","author":"Jensen","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.014_bib68","article-title":"Prevention of hepatitis C virus infection and spread in human liver chimeric mice by an anti-CD81 monoclonal antibody","author":"Ji","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib69","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/147323000803600620","article-title":"Scavenger receptor class B type I mediates cell entry of hepatitis C virus","volume":"36","author":"Jia","year":"2008","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.virol.2015.03.014_bib70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt.1604","article-title":"Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system","volume":"28","author":"Jones","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2015.03.014_bib71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1101\/sqb.2006.71.022","article-title":"Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122","volume":"71","author":"Jopling","year":"2006","journal-title":"Cold Spring Harbor Symposia Quant. Biol."},{"key":"10.1016\/j.virol.2015.03.014_bib72","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/JVI.06242-11","article-title":"Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122","volume":"86","author":"Kambara","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib73","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0006-291X(03)01047-7","article-title":"Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro","volume":"306","author":"Kato","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2015.03.014_bib74","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/lt.22099","article-title":"Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model","volume":"16","author":"Kawahara","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1016\/j.virol.2015.03.014_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virol.2015.03.014_bib76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/095632020201300603","article-title":"A cell-based model of HCV-negative-strand RNA replication utilizing a chimeric hepatitis C virus\/reporter RNA template","volume":"13","author":"King","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib77","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA","volume":"277","author":"Kolykhalov","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib78","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1128\/JVI.77.14.7843-7855.2003","article-title":"Nonstructural protein precursor NS4A\/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus","volume":"77","author":"Konan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib79","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib80","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/JVI.75.10.4614-4624.2001","article-title":"Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations","volume":"75","author":"Krieger","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2012.02.018","article-title":"Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice","volume":"57","author":"Lacek","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2015.03.014_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib83","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2353\/ajpath.2007.060789","article-title":"Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes","volume":"170","author":"Lazaro","year":"2007","journal-title":"Am. J.Pathol."},{"key":"10.1016\/j.virol.2015.03.014_bib84","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.175.3.1735","article-title":"Roles for T and NK cells in the innate immune response to Shigella flexneri","volume":"175","author":"Le-Barillec","year":"2005","journal-title":"J. Immunol."},{"issue":"812-821","key":"10.1016\/j.virol.2015.03.014_bib85","first-page":"e814","article-title":"Differential sensitivity of 5\u2032UTR-NS5A recombinants of hepatitis C virus genotypes 1\u20136 to protease and NS5A inhibitors","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib86","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1073\/pnas.1218260109","article-title":"Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib87","article-title":"Efficient infectious cell culture systems of the hepatitis C virus prototype strains HCV-1 and H77","author":"Li","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2004.12.031","article-title":"Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells","volume":"333","author":"Liang","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.014_bib89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/vir.0.016881-0","article-title":"Characterization of hepatitis C virus NS3 modifications in the context of replication","volume":"91","author":"Liefhebber","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib90","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1128\/JVI.00559-10","article-title":"Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122","volume":"84","author":"Lin","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib91","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib92","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.0511218103","article-title":"Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro","volume":"103","author":"Lindenbach","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib93","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/vir.0.055772-0","article-title":"Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures","volume":"95","author":"Liu","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib94","doi-asserted-by":"crossref","first-page":"e44965","DOI":"10.1371\/journal.pone.0044965","article-title":"A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2015.03.014_bib95","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s13365-014-0245-7","article-title":"Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18","volume":"20","author":"Liu","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.virol.2015.03.014_bib96","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/JVI.77.5.3007-3019.2003","article-title":"Viral and cellular determinants of hepatitis C virus RNA replication in cell culture","volume":"77","author":"Lohmann","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib97","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/JVI.75.3.1437-1449.2001","article-title":"Mutations in hepatitis C virus RNAs conferring cell culture adaptation","volume":"75","author":"Lohmann","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib98","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2893.2004.00525.x","article-title":"Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells","volume":"11","author":"Maekawa","year":"2004","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.virol.2015.03.014_bib101","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib102","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.2010.211292","article-title":"Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins","volume":"60","author":"Mancone","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.virol.2015.03.014_bib103","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.virol.2015.03.014_bib104","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1073\/pnas.1301764110","article-title":"Identification of transferrin receptor 1 as a hepatitis C virus entry factor","volume":"110","author":"Martin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib105","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1128\/JVI.00246-09","article-title":"Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells","volume":"83","author":"Mee","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib106","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib107","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2015.03.014_bib176","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global Distribution and Prevalence of Hepatitis C Virus Genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib108","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus","volume":"53","author":"Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib109","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"Meuleman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"Pt 9","key":"10.1016\/j.virol.2015.03.014_bib111","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1099\/0022-1317-78-9-2299","article-title":"Characterization of truncated forms of hepatitis C virus glycoproteins","volume":"78","author":"Michalak","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib112","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"186","author":"Mikkelsen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2015.03.014_bib113","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1128\/JVI.76.12.6093-6103.2002","article-title":"Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies","volume":"76","author":"Mizukoshi","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib175","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2011.12.021","article-title":"Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle","volume":"425","author":"Molina-Jimenez","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.014_bib115","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1128\/JVI.01351-12","article-title":"Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors","volume":"86","author":"Nag","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib116","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1128\/JVI.05843-11","article-title":"HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle","volume":"85","author":"Narbus","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib117","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/JVI.77.8.4781-4793.2003","article-title":"Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees","volume":"77","author":"Nascimbeni","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib118","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/JVI.80.5.2418-2428.2006","article-title":"Association between hepatitis C virus and very-low-density lipoprotein (VLDL)\/LDL analyzed in iodixanol density gradients","volume":"80","author":"Nielsen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcv.2014.03.004","article-title":"Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation","volume":"60","author":"Pawlowski","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","article-title":"Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment","volume":"154","author":"Pearson","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.virol.2015.03.014_bib121","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bmcl.2011.11.121","article-title":"Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives","volume":"22","author":"Peng","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.virol.2015.03.014_bib122","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc. Natl.ional Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib123","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.014_bib124","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.virol.2015.03.014_bib125","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1073\/pnas.0915130107","article-title":"Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures","volume":"107","author":"Ploss","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib126","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"Prentoe","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib127","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.26660","article-title":"Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors","volume":"59","author":"Ramirez","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mt.2012.151","article-title":"Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy","volume":"21","author":"Ray","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2015.03.014_bib129","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.92.11.4942","article-title":"Complete reconstitution of mouse liver with xenogeneic hepatocytes","volume":"92","author":"Rhim","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2012.03.030","article-title":"Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus","volume":"57","author":"Roelandt","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2015.03.014_bib131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2893.2009.01111.x","article-title":"Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77\/JFH1 chimeric infectious virus particles","volume":"16","author":"Russell","year":"2009","journal-title":"J. Viral. Hepat."},{"issue":"56-58","key":"10.1016\/j.virol.2015.03.014_bib132","first-page":"e57","article-title":"Replication of hepatitis C virus genotype 3a in cultured cells","volume":"144","author":"Saeed","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib133","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1128\/AAC.01256-12","article-title":"Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells","volume":"56","author":"Saeed","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib134","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib135","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1128\/JVI.01059-06","article-title":"Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells","volume":"80","author":"Sainz","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib136","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1743-422X-6-103","article-title":"Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection","volume":"6","author":"Sainz","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib137","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2015.03.014_bib138","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2015.03.014_bib139","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.0711044105","article-title":"Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization","volume":"105","author":"Scheel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.gastro.2010.11.036","article-title":"Recombinant HCV variants with NS5A from genotypes 1\u20137 have different sensitivities to an NS5A inhibitor but not interferon-alpha","volume":"140","author":"Scheel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib141","doi-asserted-by":"crossref","first-page":"e1002696","DOI":"10.1371\/journal.ppat.1002696","article-title":"Analysis of functional differences between hepatitis C virus NS5A of genotypes 1\u20137 in infectious cell culture systems","volume":"8","author":"Scheel","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2015.03.014_bib142","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1073\/pnas.1121400109","article-title":"Modeling hepatitis C virus infection using human induced pluripotent stem cells","volume":"109","author":"Schwartz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib143","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.chom.2014.01.007","article-title":"Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness","volume":"15","author":"Sheahan","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2015.03.014_bib144","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/JVI.78.6.2738-2748.2004","article-title":"Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon","volume":"78","author":"Shimakami","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib145","first-page":"17","article-title":"Cell culture systems for hepatitis C virus","volume":"369","author":"Steinmann","year":"2013","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"10.1016\/j.virol.2015.03.014_bib146","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","article-title":"Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase RIG-I.","volume":"79","author":"Sumpter","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib147","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1099\/vir.0.81334-0","article-title":"Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon","volume":"86","author":"Targett-Adams","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib148","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib149","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virusres.2005.07.012","article-title":"Trans-complementation of HCV replication by non-structural protein 5A","volume":"115","author":"Tong","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2015.03.014_bib150","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JVI.01818-10","article-title":"Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection","volume":"85","author":"Tong","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib151","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/j.gastro.2007.07.007","article-title":"Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse","volume":"133","author":"Vanwolleghem","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib152","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/hep.27196","article-title":"Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents","volume":"60","author":"Vercauteren","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2013.05.036","article-title":"Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines","volume":"444","author":"Vogt","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.014_bib154","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.014_bib155","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.03.014_bib156","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2012-302553","article-title":"Hepatitis C virus kinetics by administration of pegylated interferon-alpha in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene","volume":"62","author":"Watanabe","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.virol.2015.03.014_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(90)90134-Q","article-title":"Detection of hepatitis C viral sequences in non-A, non-B hepatitis","volume":"335","author":"Weiner","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2015.03.014_bib158","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2893.2012.01605.x","article-title":"Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper","volume":"19","author":"Welker","year":"2012","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.virol.2015.03.014_bib159","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1128\/JVI.00800-09","article-title":"Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain","volume":"83","author":"Whidby","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib160","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell. Res."},{"key":"10.1016\/j.virol.2015.03.014_bib161","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1128\/AAC.03534-14","article-title":"Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents","volume":"58","author":"Wose Kinge","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib162","doi-asserted-by":"crossref","first-page":"e1002617","DOI":"10.1371\/journal.ppat.1002617","article-title":"Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation","volume":"8","author":"Wu","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2015.03.014_bib163","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/viro.1998.9127","article-title":"Transmission of hepatitis C virus infection to tree shrews","volume":"244","author":"Xie","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.014_bib164","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1099\/vir.0.82878-0","article-title":"Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma","volume":"88","author":"Xu","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib165","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","article-title":"Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee","volume":"94","author":"Yanagi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib166","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/viro.1998.9092","article-title":"Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo","volume":"244","author":"Yanagi","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.014_bib167","first-page":"E1264","article-title":"Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.014_bib168","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.23908","article-title":"Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster","volume":"52","author":"Yang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2015.03.014_bib169","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1128\/JVI.78.15.7904-7915.2004","article-title":"Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells","volume":"78","author":"Yi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.014_bib170","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/AAC.01780-13","article-title":"Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture","volume":"58","author":"Yu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2015.03.014_bib171","first-page":"87","article-title":"Hepatitis C virus entry","volume":"369","author":"Zeisel","year":"2013","journal-title":"Curr. Top.. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2015.03.014_bib172","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:31:27Z","timestamp":1758587487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682215001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":174,"alternative-id":["S0042682215001506"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2015.03.014","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in experimental systems to study hepatitis C virus in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}